Results 151 to 160 of about 15,493 (167)

Onchocerca volvulus microfilariae in the anterior chambers of the eye and ocular adverse events after a single dose of 8 mg moxidectin or 150 µg/kg ivermectin: results of a randomized double-blind Phase 3 trial in the Democratic Republic of the Congo, Ghana and Liberia. [PDF]

open access: yesParasit Vectors
Kanza EM   +19 more
europepmc   +1 more source

Protective Immunity Induced by Vaccination With Onchocerca volvulus Tropomyosin in Rodents

open access: yesParasite Immunology, 1996
A cDNA clone of Onchocerca volvulus, designated MOv14, and encoding 136 amino-acid residues from the C-terminus of O. volvulus tropomyosin, was evaluated as a protective immunogen in two complimentary rodent models of onchocerciasis.
Mark J. Taylor   +2 more
exaly   +2 more sources

Onchocerca volvulus and Epilepsy: A Comprehensive Review Using the Bradford Hill Criteria for Causation

PLoS Neglected Tropical Diseases, 2021
Robert Colebunders   +2 more
exaly  

Characterization of an Immunodominant Onchocerca volvulus Antigen With Patient Sera and a Monoclonal Antibody.

Journal of Experimental Medicine, 1988
Rolf D Walter, D W Büttner, R Lucius
exaly  

Ivermectin Resistance in Onchocerca volvulus: Toward a Genetic Basis

PLoS Neglected Tropical Diseases, 2007
James P McCarter, Sara Lustigman
exaly  

Towards a Recombinant Antigen Vaccine Against Onchocerca volvulus

Trends in Parasitology, 2002
Sara Lustigman, Eric R James
exaly  

Home - About - Disclaimer - Privacy